[1]
|
Sarkar, A., Irwin, M., Singh, A., et al. (2016) Alzheimer’s Disease: The Silver Tsunami of the 21(st) Century. Neural Regeneration Research, 11, 693-697. https://doi.org/10.4103/1673-5374.182680
|
[2]
|
Barnes, D.E. and Yaffe, K. (2011) The Projected Effect of Risk Factor Reduction on Alzheimer’s Disease Prevalence. The Lancet Neurology, 10, 819-828. https://doi.org/10.1016/S1474-4422(11)70072-2
|
[3]
|
袁俊亮, 杨淑娜, 陈宇丹, 等. 2016《中国血管性轻度认知损害诊断指南》解读[J]. 中华老年心脑血管病杂志, 2017(19): 108-110.
|
[4]
|
Owen, J.B., Sultana, R., Aluise, C.D., et al. (2010) Oxidative Modification to LDL Receptor-Related Protein 1 in Hippocampus from Subjects with Alzheimer Disease: Implications for Aβ Accumulation in AD Brain. Free Radical Biology & Medicine, 49, 1798-1803. https://doi.org/10.1016/j.freeradbiomed.2010.09.013
|
[5]
|
Christen, Y. (2001) Oxidative Stress and Alzheimer Disease. The American Journal of Clinical Nutrition, 71, 621-629.
https://doi.org/10.1093/ajcn/71.2.621s
|
[6]
|
杨南竹, 贠相华. 尿酸代谢异常与阿尔茨海默病关系的研究进展[J]. 医学综述, 2015, 21(14): 2572-2574.
|
[7]
|
黄德弘, 刘孟渊. 阿尔茨海默病和血管性痴呆患者血脂、血糖及尿酸水平的变化[J]. 广东医学, 2013, 34(4): 587-589.
|
[8]
|
Cervellati, C., Cremonini, E., Bosi, C., et al. (2013) Systemic Oxidative Stress in Older Patients with Mild Cognitive Impairment or Late Onset Alzheimer’s Disease. Current Alzheimer Research, 10, 365-372.
https://doi.org/10.2174/1567205011310040003
|
[9]
|
Cervellati, C., Romani, A., Seripa, D., et al. (2014) Oxidative Balance, Homocysteine, and Uric Acid Levels in Older Patients with Late Onset Alzheimer’s Disease or Vascular Dementia. Journal of the Neurological Sciences, 337, 156-161. https://doi.org/10.1016/j.jns.2013.11.041
|
[10]
|
Cankurtaran, M., Yesil, Y., Kuyumcu, M.E., et al. (2013) Altered Levels of Homocysteine and Serum Natural Antioxidants Links Oxidative Damage to Alzheimer’s Disease. Journal of Alzheimer’s Disease: JAD, 33, 1051-1058.
|
[11]
|
Baldeiras, H., Santanab, I., Proenc, M.T., et al. (2008) Peripheral Ox-idative Damage in Mild Cognitive Impairment and Mild Alzheimer’s Disease. Journal of Alzheimer’s Disease, 15, 117-128. https://doi.org/10.3233/JAD-2008-15110
|
[12]
|
Carantoni, M., Zuliani, G., Munari, M.R., et al. (2000) Alzheimer Disease and Vascular Dementia: Relationships with Fasting Glucose and Insulin Levels. Dementia and Geriatric Cognitive Disorders, 11, 176-180.
https://doi.org/10.1159/000017232
|
[13]
|
Rinaldi, P., Polidori, M.C., Metastasio, A., et al. (2003) Plasma Antiox-idants Are Similarly Depleted in Mild Cognitive Impairment and in Alzheimer’s Disease. Neurobiology of Aging, 24, 915-919.
https://doi.org/10.1016/S0197-4580(03)00031-9
|
[14]
|
Pulido, R., Jimenez-Escrig, A., Orensanz, L., et al. (2005) Study of Plasma Antioxidant Status in Alzheimer’s Disease. European Journal of Neurology, 12, 531-535. https://doi.org/10.1111/j.1468-1331.2005.01000.x
|
[15]
|
Polidori, M.C., Mattioli, P., Aldred, S., et al. (2004) Plasma Antioxidant Status, Immunoglobulin g Oxidation and Lipid Peroxidation in Demented Patients: Relevance to Alzheimer Disease and Vascular Dementia. Dementia and Geriatric Cognitive Disorders, 18, 265-270. https://doi.org/10.1159/000080027
|
[16]
|
Can, M., Varlibas, F., Guven, B., et al. (2013) Ischemia Modified Al-bumin and Plasma Oxidative Stress Markers in Alzheimer’s Disease. European Neurology, 69, 377-380. https://doi.org/10.1159/000339006
|
[17]
|
Ramdane, S. (2011) Plasma Urate in Patients with Alzheimer’s Disease. Alzheimer’s and Dementia, 7, 153.
https://doi.org/10.1016/j.jalz.2011.05.411
|
[18]
|
Kim, T.S., Pae, C.U., Yoon, S.J., et al. (2006) Decreased Plasma Antioxidants in Patients with Alzheimer’s Disease. International Journal of Geriatric Psychiatry, 21, 344-348. https://doi.org/10.1002/gps.1469
|
[19]
|
Maesaka, J.K., Wolf-Klein, G., Piccione, J.M., et al. (1993) Hypouricemia, Abnormal Renal Tubular Urate Transport, and Plasma Natriuretic Factor(s) in Patients with Alzheimer’s Disease. Journal of the American Geriatrics Society, 41, 501-506. https://doi.org/10.1111/j.1532-5415.1993.tb01885.x
|
[20]
|
Al-Khateeb, E., Althaher, A., Al-Khateeb, M., et al. (2015) Relation between Uric Acid and Alzheimer’s Disease in Elderly Jordanians. Journal of Alzheimer’s Disease: JAD, 44, 859-865.
|
[21]
|
Hatanaka, H., Hanyu, H., Fukasawa, R., et al. (2015) Differences in Peripheral Oxidative Stress Markers in Alzheimer’s Disease, Vascular Dementia and Mixed Dementia Patients. Geriatrics & Gerontology International, 15, 53-58.
https://doi.org/10.1111/ggi.12659
|
[22]
|
Iulianoa, L., Monticoloa, R., Straface, G., et al. (2010) Vitamin E and Enzymatic/Oxidativestress-Driven Oxysterols in Amnestic Mildcognitive Impairment Subtypes and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 21, 1383-1392. https://doi.org/10.3233/JAD-2010-100780
|
[23]
|
Polidori, M.C. and Mecocci, P. (2002) Plasma Susceptibility to Free Radical Induced Antioxidant Consumption and Lipid Peroxidation Is Increased in Very Old Subjects with Alzheimer Disease. Journal of Alzheimer’s Disease, 4, 517-522. https://doi.org/10.3233/JAD-2002-4608
|
[24]
|
商秀丽, 张凤英, 孟令慧, 等. 阿尔茨海默病患者血尿酸水平的检测及意义[J]. 中国医科大学学报, 2009, 38(5): 333-334.
|
[25]
|
孙小康, 潘锋丰, 黄高忠, 等. 阿尔茨海默病患者认知功能与血尿酸水平的关系[J]. 老年医学与保健, 2013, 19(6): 380-382.
|
[26]
|
杨嘉辉. 阿尔茨海默病及血管性痴呆患者血尿酸检验结果分析[J]. 现代诊断与治疗, 2014(1): 161-162.
|
[27]
|
吴甜莺, 张雄, 郑永克, 等. 同型半胱氨酸、叶酸和尿酸在认知功能障碍诊断中的意义[J]. 温州医科大学学报, 2015(8): 608-611.
|
[28]
|
黄东明, 吕泽平, 覃少东, 等. 阿尔茨海默病尿酸水平相关性研究[J]. 广西医学, 2012, 34(11): 1483-1485.
|
[29]
|
王楠, 何远宏, 潘双杰, 等. 阿尔茨海默病患者认知功能及血清铜、同型半胱氨酸、尿酸水平、tau和Aβ1-42蛋白的检测[J]. 郑州大学学报(医学版), 2015, 50(3): 407-409.
|
[30]
|
周颖, 谭红, 王爱民, 等. 尿酸与阿尔茨海默病患者不同认知功能域的相关研究[J]. 中国医师杂志, 2012, 14(7): 904-906.
|
[31]
|
张琳琳, 宋宛珊, 王凯, 等. 阿尔茨海默病发病机制及药物治疗研究进展[J]. 世界中医药, 2017, 12(5): 1200-1208.
|
[32]
|
许桦, 肖世富. 阿尔茨海默病诊断和药物治疗新进展[J]. 中国神经精神疾病杂志, 2017, 43(6): 379-382.
|
[33]
|
刘云, 吴晓球. 老年痴呆症危险因素的研究进展[J]. 医学综述, 2016, 22(12): 2349-2352.
|